Pepsin in Nonacidic Refluxate Can Damage Hypopharyngeal Epithelial Cells

Abstract

These findings are perhaps the first to explain why many patients have symptoms and injury associated with nonacidic reflux, and could have important implications for the development of new therapies for reflux, such as pepsin receptor antagonists and/or irreversible inhibitors of peptic activity.